Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Clin Infect Dis
.
2022 Jan 29;74(2):366-368.
doi: 10.1093/cid/ciab411.
Authors
Pragya D Yadav
1
,
Gajanan N Sapkal
1
,
Priya Abraham
1
,
Raches Ella
2
,
Gururaj Deshpande
1
,
Deepak Y Patil
1
,
Dimpal A Nyayanit
1
,
Nivedita Gupta
3
,
Rima R Sahay
1
,
Anita M Shete
1
,
Samiran Panda
3
,
Balram Bhargava
3
,
V Krishna Mohan
2
Affiliations
1
Indian Council of Medical Research-National Institute of Virology, Pune, India.
2
Bharat Biotech International Limited, Genome Valley, Hyderabad, India.
3
Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India.
PMID:
33961693
DOI:
10.1093/cid/ciab411
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Antibodies, Neutralizing*
Antibodies, Viral*
Humans
Neutralization Tests
Substances
Antibodies, Neutralizing
Antibodies, Viral